Kálai Tamás, Balog Mária, Szabó Alíz, Gulyás Gergely, Jeko József, Sümegi Balázs, Hideg Kálmán
Department of Organic and Medicinal Chemistry, University of Pecs, H-7624 Pecs, Szigeti str. 12, Hungary.
J Med Chem. 2009 Mar 26;52(6):1619-29. doi: 10.1021/jm801476y.
4-Carboxamidobenzimidazoles were previously described as PARP inhibitor compounds. Here we report upon 4-carboxamido-1H-benzimidazoles substituted in the 2-position with nitroxides or their amine or hydroxylamine precursors. Among the new molecules, a highly active PARP inhibitor 4h (IC(50) = 14 nM) was identified with antioxidant/radical scavenger activity. We concluded that in most cases sterically hindered amines are better PARP inhibitors than their oxidized form and structural changes in the 2-substituted 4-carboxamido-1H-benzimidazoles (such as N-substitution or changing the position of the carboxamide group) were detrimental to PARP inhibition activity but not to antioxidant activity. These results indicate the advantages of combining an antioxidant nitroxide or nitroxide precursor with a PARP inhibitor molecule to decrease or eliminate the deleterious processes initiated by reactive oxygen and reactive nitrogen species (ROS and RNS). The radical scavenging capability of 4h was demonstrated by EPR study of urine collected after drug administration.
4-羧基氨基苯并咪唑先前被描述为PARP抑制剂化合物。在此,我们报道了在2-位被氮氧化物或其胺或羟胺前体取代的4-羧基氨基-1H-苯并咪唑。在这些新分子中,鉴定出一种具有抗氧化/自由基清除活性的高活性PARP抑制剂4h(IC(50)=14 nM)。我们得出结论,在大多数情况下,空间位阻胺比其氧化形式是更好的PARP抑制剂,并且2-取代的4-羧基氨基-1H-苯并咪唑中的结构变化(如N-取代或改变羧酰胺基团的位置)对PARP抑制活性有害,但对抗氧化活性无害。这些结果表明将抗氧化氮氧化物或氮氧化物前体与PARP抑制剂分子结合以减少或消除由活性氧和活性氮物种(ROS和RNS)引发的有害过程的优势。通过对给药后收集的尿液进行EPR研究证明了4h的自由基清除能力。